Robert W. Duggan, Co-Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 14,300,957 shares at $18.74 ($268.0M) on 2025-10-21, disclosed to the SEC on 2025-10-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.74 | 26,680 | $500K | 0.2% |
| 2 | $18.74 | 26,680 | $500K | 0.2% |
| 3 | $18.74 | 266,808 | $5.0M | 1.9% |
| 4 | $18.74 | 13,980,789 | $262.0M | 97.8% |
| Total | $18.74 avg | 14,300,957 | $268.0M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |
| SMMT | BUY | 2025-09-11 | $11.9M | — | Filing → |